NCT03871803View on ClinicalTrials.gov

β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR)

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 27, 2021

Study Completion Date

February 27, 2021

Conditions
Heart Failure With Normal Ejection FractionChronotropic Incompetence
Interventions
DRUG

Controlled withdrawal of beta-blockers

Controlled withdrawal of previos doses of beta-blockers after diagnosis of chronotropic incompetence

DIAGNOSTIC_TEST

Cardiopulmonary Exercise Testing

Cardiopulmonary Exercise Testing to evaluate the chronotropic incompetence and the primary endpoint (functional capacity)

Trial Locations (1)

46010

INCLIVA, Valencia

All Listed Sponsors
lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT03871803 - β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR) | Biotech Hunter | Biotech Hunter